Dr. Ami Claxton, MS, PHD - DaVita Clinical Research - Director

Dr. Ami Claxton

MS, PHD

DaVita Clinical Research

Director

Cary, NC | United States

Main Specialties: Public Health

Additional Specialties: Health Economics & Outcomes Research

Dr. Ami Claxton, MS, PHD - DaVita Clinical Research - Director

Dr. Ami Claxton

MS, PHD

Introduction

Primary Affiliation: DaVita Clinical Research - Cary, NC , United States

Specialties:

Additional Specialties:

Publications

5Publications

106Reads

-Profile Views

78PubMed Central Citations

Economic implications of treatment-resistant depression among employees.

Pharmacoeconomics 2004 ;22(6):363-73

Analysis Group Inc, Boston, Massachusetts 02199, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/00019053-200422060-00003DOI Listing
June 2004
22 Reads
12 Citations
2.450 Impact Factor

Attention-deficit/hyperactivity disorder: increased costs for patients and their families.

J Am Acad Child Adolesc Psychiatry 2003 Dec;42(12):1415-23

Eli Lilly and Company, Indianapolis, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00004583-200312000-00008DOI Listing
December 2003
21 Reads
35 Citations
7.260 Impact Factor

Economic cost and epidemiological characteristics of patients with fibromyalgia claims.

J Rheumatol 2003 Jun;30(6):1318-25

Eli Lilly and Company, Indianapolis, Indiana 46285, USA.

View Article

Download full-text PDF

Source
June 2003
12 Reads
23 Citations
3.190 Impact Factor

Identification of a claims data "signature" and economic consequences for treatment-resistant depression.

J Clin Psychiatry 2002 Aug;63(8):717-26

Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/jcp.v63n0810DOI Listing
August 2002
26 Reads
6 Citations
5.500 Impact Factor